STOCK TITAN

[Form 4] Amrize Ltd Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Amrize Ltd (AMRZ) reports that director Roth Pellanda Katja Nicole received 2,958 ordinary shares as a restricted stock unit award under the Amrize Ltd 2025 Omnibus Incentive Plan. The transaction is recorded as an acquisition and the award shows a reported price of $0, indicating the shares were granted rather than purchased.

The award vests on the earlier of the one-year anniversary of the grant date and the issuer's next regular annual meeting of shareholders, and following the transaction the reporting person beneficially owns 2,958 shares directly. No derivative securities were reported in this filing.

Amrize Ltd (AMRZ) comunica che il direttore Roth Pellanda Katja Nicole ha ricevuto 2.958 azioni ordinarie come premio in unità di azioni vincolate (restricted stock units) nell'ambito del Piano Omnibus Incentive 2025 di Amrize Ltd. L'operazione è registrata come acquisizione e il premio riporta un prezzo dichiarato di $0, indicando che le azioni sono state assegnate e non acquistate.

Il premio matura al primo verificarsi tra il primo anniversario della data di assegnazione e la prossima assemblea ordinaria degli azionisti dell'emittente; a seguito dell'operazione la persona che effettua la comunicazione detiene direttamente e beneficiariamente 2.958 azioni. Nel documento non risultano segnalati strumenti derivati.

Amrize Ltd (AMRZ) informa que la directora Roth Pellanda Katja Nicole recibió 2.958 acciones ordinarias como adjudicación en unidades de acciones restringidas (restricted stock units) bajo el Plan Omnibus de Incentivos 2025 de Amrize Ltd. La operación figura como una adquisición y el precio declarado es de $0, lo que indica que las acciones fueron otorgadas y no compradas.

La adjudicación vence en la fecha que ocurra primero: el primer aniversario de la fecha de concesión o la próxima junta general ordinaria de la emisora; tras la operación, la persona informante posee directamente y de forma beneficiaria 2.958 acciones. No se reportaron valores derivados en este documento.

Amrize Ltd (AMRZ)는 이사 Roth Pellanda Katja Nicole이 Amrize Ltd 2025 Omnibus 인센티브 플랜에 따라 제한주식유닛(RSU) 보상으로 2,958 보통주를 수령했다고 보고합니다. 거래는 취득으로 기록되었으며 보고된 가격은 $0으로, 주식이 구매된 것이 아니라 부여된 것임을 나타냅니다.

보상은 부여일로부터 1주년 또는 발행회사의 다음 정기 주주총회 중 더 이른 시점에 취득됩니다. 이번 거래 이후 보고인은 직접적으로 및 실질적으로 2,958주를 보유하게 되었으며, 본 신고서에는 파생증권이 보고되지 않았습니다.

Amrize Ltd (AMRZ) indique que la directrice Roth Pellanda Katja Nicole a reçu 2 958 actions ordinaires au titre d'une attribution d'unités d'actions restreintes dans le cadre du Plan d'incitation omnibus 2025 d'Amrize Ltd. La transaction est enregistrée comme une acquisition et le prix déclaré est de 0 $, ce qui montre que les actions ont été attribuées et non achetées.

L'attribution devient acquise au premier des deux événements suivants : le premier anniversaire de la date d'octroi ou la prochaine assemblée générale ordinaire de l'émetteur ; à la suite de la transaction, la personne déclarante détient directement et à titre bénéficiaire 2 958 actions. Aucun instrument dérivé n'a été signalé dans ce dépôt.

Amrize Ltd (AMRZ) meldet, dass Direktorin Roth Pellanda Katja Nicole 2.958 Stammaktien als Restricted Stock Unit-Zuteilung im Rahmen des Amrize Ltd 2025 Omnibus Incentive Plan erhalten hat. Die Transaktion ist als Erwerb verbucht und der gemeldete Preis beträgt $0, was darauf hinweist, dass die Aktien zugesprochen und nicht gekauft wurden.

Die Zuteilung fällt zum jeweils früheren Zeitpunkt: dem ersten Jahrestag des Gewährungsdatums oder der nächsten ordentlichen Hauptversammlung des Emittenten; nach der Transaktion besitzt die meldende Person unmittelbar wirtschaftlich 2.958 Aktien. In dieser Meldung wurden keine derivativen Wertpapiere angegeben.

Positive
  • 2,958 ordinary shares were granted to a director as restricted stock units under the Amrize Ltd 2025 Omnibus Incentive Plan
  • The award vests on the earlier of the one-year anniversary of the grant or the issuer's next regular annual meeting of shareholders
  • Following the reported transaction the reporting person beneficially owns 2,958 shares in direct form
Negative
  • None.

Insights

TL;DR: Director received a non-cash RSU award of 2,958 shares, recorded as a direct ownership increase.

The Form 4 documents a non-derivative grant: 2,958 ordinary shares awarded as restricted stock units under the company's 2025 Omnibus Incentive Plan and reported as an acquisition with a price of $0. The award's vesting is tied to the earlier of one year or the next annual meeting, which is a time-limited schedule rather than multi-year cliff or graded vesting. The filing shows no related derivative holdings, and ownership is reported as direct.

TL;DR: Routine director compensation via RSUs with a short vesting trigger; disclosure aligns with Section 16 reporting requirements.

The disclosure identifies the reporting person as a director and specifies the RSU award’s vesting condition: earlier of one-year anniversary or next annual meeting. The form indicates direct beneficial ownership of 2,958 shares after the grant. This is a standard compensation disclosure for insiders and follows required reporting format for non-derivative securities.

Amrize Ltd (AMRZ) comunica che il direttore Roth Pellanda Katja Nicole ha ricevuto 2.958 azioni ordinarie come premio in unità di azioni vincolate (restricted stock units) nell'ambito del Piano Omnibus Incentive 2025 di Amrize Ltd. L'operazione è registrata come acquisizione e il premio riporta un prezzo dichiarato di $0, indicando che le azioni sono state assegnate e non acquistate.

Il premio matura al primo verificarsi tra il primo anniversario della data di assegnazione e la prossima assemblea ordinaria degli azionisti dell'emittente; a seguito dell'operazione la persona che effettua la comunicazione detiene direttamente e beneficiariamente 2.958 azioni. Nel documento non risultano segnalati strumenti derivati.

Amrize Ltd (AMRZ) informa que la directora Roth Pellanda Katja Nicole recibió 2.958 acciones ordinarias como adjudicación en unidades de acciones restringidas (restricted stock units) bajo el Plan Omnibus de Incentivos 2025 de Amrize Ltd. La operación figura como una adquisición y el precio declarado es de $0, lo que indica que las acciones fueron otorgadas y no compradas.

La adjudicación vence en la fecha que ocurra primero: el primer aniversario de la fecha de concesión o la próxima junta general ordinaria de la emisora; tras la operación, la persona informante posee directamente y de forma beneficiaria 2.958 acciones. No se reportaron valores derivados en este documento.

Amrize Ltd (AMRZ)는 이사 Roth Pellanda Katja Nicole이 Amrize Ltd 2025 Omnibus 인센티브 플랜에 따라 제한주식유닛(RSU) 보상으로 2,958 보통주를 수령했다고 보고합니다. 거래는 취득으로 기록되었으며 보고된 가격은 $0으로, 주식이 구매된 것이 아니라 부여된 것임을 나타냅니다.

보상은 부여일로부터 1주년 또는 발행회사의 다음 정기 주주총회 중 더 이른 시점에 취득됩니다. 이번 거래 이후 보고인은 직접적으로 및 실질적으로 2,958주를 보유하게 되었으며, 본 신고서에는 파생증권이 보고되지 않았습니다.

Amrize Ltd (AMRZ) indique que la directrice Roth Pellanda Katja Nicole a reçu 2 958 actions ordinaires au titre d'une attribution d'unités d'actions restreintes dans le cadre du Plan d'incitation omnibus 2025 d'Amrize Ltd. La transaction est enregistrée comme une acquisition et le prix déclaré est de 0 $, ce qui montre que les actions ont été attribuées et non achetées.

L'attribution devient acquise au premier des deux événements suivants : le premier anniversaire de la date d'octroi ou la prochaine assemblée générale ordinaire de l'émetteur ; à la suite de la transaction, la personne déclarante détient directement et à titre bénéficiaire 2 958 actions. Aucun instrument dérivé n'a été signalé dans ce dépôt.

Amrize Ltd (AMRZ) meldet, dass Direktorin Roth Pellanda Katja Nicole 2.958 Stammaktien als Restricted Stock Unit-Zuteilung im Rahmen des Amrize Ltd 2025 Omnibus Incentive Plan erhalten hat. Die Transaktion ist als Erwerb verbucht und der gemeldete Preis beträgt $0, was darauf hinweist, dass die Aktien zugesprochen und nicht gekauft wurden.

Die Zuteilung fällt zum jeweils früheren Zeitpunkt: dem ersten Jahrestag des Gewährungsdatums oder der nächsten ordentlichen Hauptversammlung des Emittenten; nach der Transaktion besitzt die meldende Person unmittelbar wirtschaftlich 2.958 Aktien. In dieser Meldung wurden keine derivativen Wertpapiere angegeben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Roth Pellanda Katja Nicole

(Last) (First) (Middle)
GRAFENAUWEG 8

(Street)
ZUG V8 6300

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Amrize Ltd [ AMRZ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 08/11/2025 A 2,958(1) A $0 2,958 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Restricted stock unit award to the reporting person pursuant to the Amrize Ltd 2025 Omnibus Incentive Plan. The award vests on the earlier of the one-year anniversary of the grant date and the date of the issuer's next regular annual meeting of shareholders.
Hans Weinburger, Attorney-in-Fact 08/13/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for AMRZ?

The reporting person is Roth Pellanda Katja Nicole, identified as a director of Amrize Ltd.

What transaction is reported on the AMRZ Form 4?

An acquisition of 2,958 ordinary shares granted as restricted stock units under the 2025 Omnibus Incentive Plan.

When does the awarded RSU vest according to the filing?

The award vests on the earlier of the one-year anniversary of the grant date or the issuer's next regular annual meeting of shareholders.

What price was reported for the shares on the AMRZ Form 4?

The transaction is reported with a price of $0, indicating the shares were granted rather than purchased.

How many shares does the reporting person own after the transaction?

The reporting person beneficially owns 2,958 ordinary shares following the reported transaction.
Amrize Ltd

NYSE:AMRZ

AMRZ Rankings

AMRZ Latest News

AMRZ Latest SEC Filings

AMRZ Stock Data

26.86B
506.75M
7%
19.44%
0.45%
Building Materials
Cement, Hydraulic
Link
Switzerland
ZUG